The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia
Clinical trial NCT05004259 · COMPLETED
Trial details
- NCT number
- NCT05004259
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2024-09-21
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.